These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1744635)

  • 1. Low dose desipramine treatment of cocaine-related panic attacks.
    Bystritsky A; Ackerman DL; Pasnau RO
    J Nerv Ment Dis; 1991 Dec; 179(12):755-8. PubMed ID: 1744635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine in agoraphobia with panic attacks: an open, fixed-dose study.
    Lydiard RB
    J Clin Psychopharmacol; 1987 Aug; 7(4):258-60. PubMed ID: 3624509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine-associated panic attacks in methadone-maintained patients.
    Rosen MI; Kosten T
    Am J Drug Alcohol Abuse; 1992; 18(1):57-62. PubMed ID: 1314016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial reaction and subsequent response to antidepressants in panic patients.
    Bystritsky A; Pasnau RO
    Am J Psychiatry; 1990 Nov; 147(11):1575. PubMed ID: 2221181
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ; Harmatz JS; Shader RI
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    Pecknold JC; Luthe L; Iny L; Ramdoyal D
    J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panic disorder and panic attack].
    Abbar M
    Encephale; 1996 Dec; 22 Spec No 5():13-8. PubMed ID: 9138941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder: treatment with valproate.
    Woodman CL; Noyes R
    J Clin Psychiatry; 1994 Apr; 55(4):134-6. PubMed ID: 8071256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
    Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
    J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cocaine-induced panic disorder.
    Louie AK; Lannon RA; Ketter TA
    Am J Psychiatry; 1989 Jan; 146(1):40-4. PubMed ID: 2912249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine-desipramine protocol in treatment of cocaine addiction.
    Giannini AJ; Billett W
    J Clin Pharmacol; 1987 Aug; 27(8):549-54. PubMed ID: 3308977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-fearful vs. fearful panic attacks: a general population study from the National Comorbidity Survey.
    Chen J; Tsuchiya M; Kawakami N; Furukawa TA
    J Affect Disord; 2009 Jan; 112(1-3):273-8. PubMed ID: 18534684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.